Pfizer Sues Generic Maker Over Neosporin Trademark

Law360, New York (October 12, 2006, 12:00 AM EDT) -- Looking to protect its popular first aid antibiotic ointment Neosporin, Pfizer Inc. has filed a trademark suit against a generic pharmaceutical company alleging that its packaging for its ointments is too similar.

Pfizer and its subsidiary, Warner-Lambert Company LLC, brought the suit against generic pharmaceutical company Actavis in the U.S. District Court for the Southern District of New York on Oct. 6, claiming Actavis is diluting its Neosporin trademark.

The Brooklyn, N.Y.-based company alleged that Actavis is using a gold color on packages and tubes that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.